R.Sh. Khasanov1, I.R. Safin1,2, D.V. Rukavishnikov2, A.Yu. Rodionova2
1Kazan State Medical Academy ― Branch Campus of the FSBEI FPE RMACPE MOH Russia, Kazan
- Tatarstan Cancer Center, Kazan
Safin Ildar R. ― Cand. of Sci. (Med.), Associate Professor at the Department of Traumatology and Orthopedics of Kazan State Medical Academy ― Branch Campus of the FSBEI FPE RMACPE MOH Russia, oncologist of the Tatarstan Cancer Center, Researcher ID: E-6654-2019, ORCID: 0000-0001-7728-4863, Author ID: 846356
29 Sibirskiy Tract, Kazan, 420029, Russian Federation, tel. +7-903-343-38-37, e-mail: firstname.lastname@example.org
Abstract. According to the prevalence of bone sarcomas, chondrosarcoma ranks second after osteosarcoma and accounts for 10-15% of all cases of primary malignant bone tumors (90% of this number accounts for primary chondrosarcoma). Ribs and sternum are a fairly common localization of chondrosarcoma (about 12% of cases). The main method of treatment for chondrosarcoma of the sternum and ribs is the surgical method. However, in mesenchymal variant of chondrosarcoma and high-grade chondrosarcoma treatment is carried out according to the osteosarcoma protocol (neoadjuvant chemotherapy-surgical treatment – adjuvant chemotherapy). Relapses after surgical treatment of chondrosarcoma with lesions of the sternum or ribs can reach 50%.
Key words: chondrosarcoma, relapse, reconstructive stage.